FDA Gives MedWatch Users Grace Period To Switch To New Reporting Forms
This article was originally published in The Gray Sheet
Executive Summary
Medical device manufacturers and users have until Aug. 17 to complete the transition to MDUFMA-compliant adverse event reporting forms
You may also be interested in...
Second MedWatch Form Revision In Two Years Is Burdensome – AdvaMed
FDA should grant a six-month grace period for firms to come into compliance with changes to the MedWatch adverse event reporting form, according to AdvaMed
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.